Literature DB >> 10560618

Effects of ulcerative colitis activity on plasma and mucosal prostaglandin E2 concentration.

A Wiercińska-Drapało1, R Flisiak, D Prokopowicz.   

Abstract

The aim of this study was to determine effects of changes in ulcerative colitis activity on mucosal and plasma PGE2 concentrations measured with an EIA in 49 patients who underwent sigmoidoscopy. The disease was diagnosed in 37 patients. Twelve patients with normal colonic mucosa served as controls. Patients were divided into three groups depending on the changes of endoscopic picture during a three-month follow-up. Some laboratory markers of the disease activity, such as C-reactive protein, albumin, gamma-globulin and hemoglobin concentrations, sedimentation rate, and white blood and platelets counts, were also evaluated. Initial examination revealed a significant, positive correlation of mucosal and plasma PGE2 concentration with endoscopic score. Follow-up of patients without significant progression of mucosal changes revealed constant and close to normal concentration of mucosal PGE2. Plasma PGE2 was higher at the second examination, yet without significant difference. Improvement of endoscopic picture resulted in significant decrease of plasma and mucosal PGE2 concentrations. Worsening of mucosal changes reflected endoscopically was associated with significant increase of PGE2. There were no remarkable changes in the values of analyzed laboratory markers of the disease activity. These results indicate the usefulness of mucosal or plasma PGE2 measurement as a possible prognostic marker in patients with ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10560618     DOI: 10.1016/s0090-6980(99)00032-5

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  12 in total

1.  Expression of COX-2 in platelet-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signaling.

Authors:  Dan A Dixon; Neal D Tolley; Kristi Bemis-Standoli; Mark L Martinez; Andrew S Weyrich; Jason D Morrow; Stephen M Prescott; Guy A Zimmerman
Journal:  J Clin Invest       Date:  2006-09-21       Impact factor: 14.808

Review 2.  Mechanistic aspects of COX-2 expression in colorectal neoplasia.

Authors:  Dan A Dixon; Fernando F Blanco; Annalisa Bruno; Paola Patrignani
Journal:  Recent Results Cancer Res       Date:  2013

Review 3.  Selenium and selenoproteins in prostanoid metabolism and immunity.

Authors:  Fenghua Qian; Sougat Misra; K Sandeep Prabhu
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-01-30       Impact factor: 8.250

4.  Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine.

Authors:  Masayuki Fukata; Anli Chen; Arielle Klepper; Suneeta Krishnareddy; Arunan S Vamadevan; Lisa S Thomas; Ruliang Xu; Hiroyasu Inoue; Moshe Arditi; Andrew J Dannenberg; Maria T Abreu
Journal:  Gastroenterology       Date:  2006-09       Impact factor: 22.682

5.  The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut.

Authors:  Kenji Kabashima; Tomomi Saji; Takahiko Murata; Miyako Nagamachi; Toshiyuki Matsuoka; Eri Segi; Kazuhito Tsuboi; Yukihiko Sugimoto; Takuya Kobayashi; Yoshiki Miyachi; Atsushi Ichikawa; Shuh Narumiya
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

6.  The role of PGE2 in intestinal inflammation and tumorigenesis.

Authors:  David C Montrose; Masako Nakanishi; Robert C Murphy; Simona Zarini; Jeremy P McAleer; Anthony T Vella; Daniel W Rosenberg
Journal:  Prostaglandins Other Lipid Mediat       Date:  2014-10-22       Impact factor: 3.072

7.  Expansion of CD11b+Ly6Ghigh and CD11b+CD49d+ myeloid cells with suppressive potential in mice with chronic inflammation and light-at-night-induced circadian disruption.

Authors:  Yuliya V Perfilyeva; Nurshat Abdolla; Yekaterina O Ostapchuk; Raikhan Tleulieva; Vladimir C Krasnoshtanov; Nikolai N Belyaev
Journal:  Inflamm Res       Date:  2017-04-28       Impact factor: 4.575

8.  Glabridin, a functional compound of liquorice, attenuates colonic inflammation in mice with dextran sulphate sodium-induced colitis.

Authors:  H-S Kwon; S-M Oh; J-K Kim
Journal:  Clin Exp Immunol       Date:  2007-11-14       Impact factor: 4.330

9.  Supplementation of arachidonic acid-enriched oil increases arachidonic acid contents in plasma phospholipids, but does not increase their metabolites and clinical parameters in Japanese healthy elderly individuals: a randomized controlled study.

Authors:  Saki Kakutani; Yoshiyuki Ishikura; Norifumi Tateishi; Chika Horikawa; Hisanori Tokuda; Masanori Kontani; Hiroshi Kawashima; Yutaka Sakakibara; Yoshinobu Kiso; Hiroshi Shibata; Ikuo Morita
Journal:  Lipids Health Dis       Date:  2011-12-22       Impact factor: 3.876

10.  Regulatory effects of glycyrrhizae radix extract on DSS-induced ulcerative colitis.

Authors:  Yong-Deok Jeon; Keuk-Soo Bang; Min-Kyoung Shin; Jong-Hyun Lee; Young-Nam Chang; Jong-Sik Jin
Journal:  BMC Complement Altern Med       Date:  2016-11-16       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.